Lv4
558 积分 2024-02-27 加入
Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications
1小时前
待确认
Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population
1小时前
待确认
Resolving Metabolic Dysfunction-associated Steatotic Liver Disease Reduces Subclinical Cardiovascular Damage in Chinese Youths
1小时前
待确认
Association between systemic inflammation markers and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease
1小时前
待确认
Impact of Metabolic Dysfunction–associated Steatotic Liver Disease on Cardiovascular Structure, Function, and the Risk of Heart Failure
1小时前
待确认
Liver and atherosclerotic risk of alcohol consumption in patients with metabolic dysfunction-associated Steatotic Liver Disease
1小时前
待确认
Hs-CRP and HOMA-IR: include them in the MASLD definition, or treat them as mediators between MASLD and atherosclerotic cardiovascular disease?
1小时前
待确认
Electrocardiogram-based machine learning for risk stratification of patients with suspected acute coronary syndrome
1天前
待确认
Reconsidering Cardiovascular Risk Assessment in Patients With MASLD
7天前
已完结
Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohort
7天前
已完结
皖公网安备34019202002308
